Mary E Norton

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Follow-up of sonographically detected soft markers for fetal aneuploidy
    Mary E Norton
    Stanford University School of Medicine, 300 Pasteur Drive, HH333, Stanford, CA 94305 Electronic address
    Semin Perinatol 37:365-9. 2013
  2. doi Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University Lucile Packard Children s Hospital, CA 94305, USA
    Am J Obstet Gynecol 207:137.e1-8. 2012
  3. doi Effects of changes in prenatal aneuploidy screening policies in an integrated health care system
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:265-71. 2013
  4. pmc Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context
    Megan Allyse
    Stanford Center for Biomedical Ethics, Stanford, CA 94305 5417, USA
    Hum Reprod 27:3123-31. 2012
  5. doi Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:847-50. 2013
  6. pmc Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation
    Lauren C Sayres
    Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94301, USA
    Prenat Diagn 31:1070-6. 2011
  7. doi Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
    Shilpa Chetty
    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
    Prenat Diagn 33:542-6. 2013
  8. ncbi Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis
    Aaron B Caughey
    Department of Obstetrics and Gynecology, University of California, San Francisco, USA
    Am J Obstet Gynecol 187:1239-45. 2002
  9. ncbi Evaluation of serial urine viral cultures for the diagnosis of cytomegalovirus infection in neonates and infants
    Karen M Chisholm
    1 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
    Pediatr Dev Pathol 17:176-80. 2014
  10. doi Nuchal translucency measurement in fetuses with spinal muscular atrophy
    Neda Zadeh
    Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, CA, USA
    Prenat Diagn 31:327-30. 2011

Detail Information

Publications11

  1. ncbi Follow-up of sonographically detected soft markers for fetal aneuploidy
    Mary E Norton
    Stanford University School of Medicine, 300 Pasteur Drive, HH333, Stanford, CA 94305 Electronic address
    Semin Perinatol 37:365-9. 2013
    ....
  2. doi Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University Lucile Packard Children s Hospital, CA 94305, USA
    Am J Obstet Gynecol 207:137.e1-8. 2012
    ..We sought to evaluate performance of a noninvasive prenatal test for fetal trisomy 21 (T21) and trisomy 18 (T18)...
  3. doi Effects of changes in prenatal aneuploidy screening policies in an integrated health care system
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:265-71. 2013
    ..To estimate changes in rates of prenatal testing for aneuploidy over a 5-year period in a large integrated health care system...
  4. pmc Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context
    Megan Allyse
    Stanford Center for Biomedical Ethics, Stanford, CA 94305 5417, USA
    Hum Reprod 27:3123-31. 2012
    ..We argue that there is an urgent need for policy-makers, regulators and professional societies to provide guidance on the most efficient and ethical manner for such tests to be introduced into clinical practice in the USA...
  5. doi Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint
    Mary E Norton
    Department of Obstetrics and Gynecology, Stanford University School of Medicine Lucile Packard Children s Hospital, Stanford, California 94305, USA
    Obstet Gynecol 121:847-50. 2013
    ..True cost-utility analyses will be needed to determine the actual clinical efficacy of this approach in the general prenatal population...
  6. pmc Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation
    Lauren C Sayres
    Stanford Center for Biomedical Ethics, Stanford University, Stanford, CA 94301, USA
    Prenat Diagn 31:1070-6. 2011
    ..To provide a preliminary assessment of obstetric healthcare provider opinions surrounding implementation of cell-free fetal DNA testing...
  7. doi Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening
    Shilpa Chetty
    Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA
    Prenat Diagn 33:542-6. 2013
    ..The aim of this study was to investigate how the introduction of noninvasive prenatal testing (NIPT) impacted women's testing choices following a positive prenatal screening (PNS) result...
  8. ncbi Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis
    Aaron B Caughey
    Department of Obstetrics and Gynecology, University of California, San Francisco, USA
    Am J Obstet Gynecol 187:1239-45. 2002
    ..The purpose of this study was to perform a cost-effectiveness analysis that compared the first- and second- trimester screening tools for Down syndrome...
  9. ncbi Evaluation of serial urine viral cultures for the diagnosis of cytomegalovirus infection in neonates and infants
    Karen M Chisholm
    1 Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
    Pediatr Dev Pathol 17:176-80. 2014
    ..Though SVC was more sensitive than RVC, the risk of SVC failure supports the use of multimodality testing to optimize detection...
  10. doi Nuchal translucency measurement in fetuses with spinal muscular atrophy
    Neda Zadeh
    Department of Pediatrics, Division of Medical Genetics, Stanford University, Stanford, CA, USA
    Prenat Diagn 31:327-30. 2011
    ..Our goal is to determine whether SMA in infants is associated with a history of an increased NT measurement during pregnancy...
  11. pmc A first look at chorioamnionitis management practice variation among US obstetricians
    Mara B Greenberg
    Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Lucile Packard Children s Hospital at Stanford, Stanford University, 300 Pasteur Drive HH333, Stanford, CA 94305, USA
    Infect Dis Obstet Gynecol 2012:628362. 2012
    ..This may represent a dearth of level I evidence. Future prospective clinical trials may provide more evidence-based practice recommendations for diagnosis and treatment of chorioamnionitis...